Texas 2019 - 86th Regular

Texas House Bill HB3369 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 86R13693 SCL-F
22 By: Parker H.B. No. 3369
33
44
55 A BILL TO BE ENTITLED
66 AN ACT
77 relating to advance directives and health care and treatment
88 decisions.
99 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1010 SECTION 1. Section 166.002, Health and Safety Code, is
1111 amended by adding Subdivision (16) to read as follows:
1212 (16) "Reasonable medical judgment" means a medical
1313 judgment that would be made by a reasonably prudent physician,
1414 knowledgeable about the case and the treatment possibilities with
1515 respect to the medical conditions involved.
1616 SECTION 2. Sections 166.045(c) and (d), Health and Safety
1717 Code, are amended to read as follows:
1818 (c) If an attending physician refuses to comply with a
1919 directive or treatment decision for a reason permitted by Section
2020 166.046(a-1) and not prohibited by Section 166.0455 and does not
2121 wish to follow the procedure established under Section 166.046,
2222 life-sustaining treatment shall be provided to the patient, but
2323 only until a reasonable opportunity has been afforded for the
2424 transfer of the patient to another physician or health care
2525 facility willing to comply with the directive or treatment
2626 decision.
2727 (d) A physician, health professional acting under the
2828 direction of a physician, or health care facility is not civilly or
2929 criminally liable or subject to review or disciplinary action by
3030 the person's appropriate licensing board if the person has complied
3131 with the procedures and limitations outlined in Sections 166.0455
3232 and [Section] 166.046.
3333 SECTION 3. Subchapter B, Chapter 166, Health and Safety
3434 Code, is amended by adding Section 166.0455 to read as follows:
3535 Sec. 166.0455. LIMITATION ON REFUSAL TO EFFECTUATE CERTAIN
3636 ADVANCE DIRECTIVES OR TREATMENT DECISIONS. A physician or other
3737 health care professional, a health care facility, or an ethics or
3838 medical committee shall not override or refuse to honor and comply
3939 with a patient's advance directive or a health care or treatment
4040 decision made by or on behalf of a patient that directs the
4141 provision of life-sustaining treatment and shall not consider
4242 life-sustaining treatment to be inappropriate treatment under
4343 Section 166.046 based on:
4444 (1) the lesser value the physician or professional,
4545 facility, or committee places on sustaining the life of an elderly,
4646 disabled, or terminally ill patient compared to the value of
4747 sustaining the life of a patient who is younger, not disabled, or
4848 not terminally ill;
4949 (2) a disagreement between the physician or
5050 professional, facility, or committee and the patient, or the person
5151 authorized to make a treatment decision for the patient under
5252 Section 166.039, over the greater weight the patient or person
5353 places on sustaining the patient's life than the risk of
5454 disability; or
5555 (3) the financial condition of the patient.
5656 SECTION 4. Section 166.046, Health and Safety Code, is
5757 amended by amending Subsections (a), (b), (c), (d), (e), and (g) and
5858 adding Subsections (a-1), (a-2), and (c-1) to read as follows:
5959 (a) If an attending physician refuses to honor or comply
6060 with a patient's advance directive or a health care or treatment
6161 decision made by or on behalf of a patient for a reason permitted by
6262 Subsection (a-1) and not prohibited by Section 166.0455, the
6363 physician's refusal shall be reviewed by an ethics or medical
6464 committee. The attending physician may not be a member of that
6565 committee. The patient shall be given life-sustaining treatment
6666 during the review. A person may not coerce or attempt to coerce a
6767 physician not to comply with a patient's advance directive or a
6868 health care or treatment decision made by or on behalf of a patient
6969 by threatening or implementing adverse employment decisions or
7070 professional discipline.
7171 (a-1) The ethics or medical committee reviewing the
7272 physician's refusal under Subsection (a) shall not consider
7373 life-sustaining treatment inappropriate unless, based on
7474 reasonable medical judgment, the life-sustaining treatment
7575 requested by or on behalf of the patient is:
7676 (1) futile because the treatment is physiologically
7777 ineffective in achieving the specific intended benefit to the
7878 patient as intended by or on behalf of the patient; or
7979 (2) medically inappropriate because providing the
8080 treatment to the patient would clearly create a substantially
8181 greater risk of causing or hastening the death of the patient than
8282 would withholding or withdrawing the treatment.
8383 (a-2) An ethics or medical committee shall record a meeting
8484 held under this section.
8585 (b) The patient, the patient's attorney, the patient's
8686 advocate, or the person responsible for the health care decisions
8787 of the individual who has made the decision regarding the directive
8888 or treatment decision:
8989 (1) may be given a written description of the ethics or
9090 medical committee review process and any other policies and
9191 procedures related to this section adopted by the health care
9292 facility;
9393 (2) unless the patient or person responsible for the
9494 health care decisions of the patient requests an earlier meeting,
9595 must [shall] be informed in writing [of the committee review
9696 process] not less than seven days [48 hours] before the meeting
9797 called to discuss the patient's directive of:
9898 (A) the committee review process;
9999 (B) the right to representation by an attorney
100100 and patient advocate present at the committee review meeting;
101101 (C) the date, time, and location of the meeting;
102102 and
103103 (D) the name and title of each of the individuals
104104 attending the meeting [, unless the time period is waived by mutual
105105 agreement];
106106 (3) at the time of being so informed, shall be
107107 provided:
108108 (A) a copy of the appropriate statement set forth
109109 in Section 166.052; and
110110 (B) a copy of the registry list of health care
111111 providers and referral groups that have volunteered their readiness
112112 to consider accepting transfer or to assist in locating a provider
113113 willing to accept transfer that is posted on the website maintained
114114 by the department under Section 166.053; and
115115 (4) is entitled to:
116116 (A) attend and participate in the entire meeting;
117117 (B) receive a written explanation of the decision
118118 reached during the review process;
119119 (C) receive a copy of the portion of the
120120 patient's medical record related to the treatment received by the
121121 patient in the facility for the lesser of:
122122 (i) the period of the patient's current
123123 admission to the facility; or
124124 (ii) the preceding 30 calendar days; [and]
125125 (D) receive a copy of all of the patient's
126126 reasonably available diagnostic results and reports related to the
127127 medical record provided under Paragraph (C);
128128 (E) during the committee review meeting, have an
129129 opportunity to:
130130 (i) address the committee and ask questions
131131 of the committee and others attending the meeting; and
132132 (ii) respond to the attending physician's
133133 or ethics or medical committee's statements; and
134134 (F) after the ethics or medical committee has
135135 rendered a decision:
136136 (i) receive a written explanation of the
137137 ethics or medical committee's decision, including, if applicable,
138138 an explanation of why the requested treatment may be futile and
139139 physiologically ineffective or medically inappropriate as
140140 described by Subsection (a-1); and
141141 (ii) receive a recording of the committee
142142 review meeting.
143143 (c) The written explanation required by Subsections
144144 [Subsection] (b)(4)(B) and (F) must be included in the patient's
145145 medical record.
146146 (c-1) The ethics or medical committee shall not approve
147147 withdrawing or withholding life-sustaining treatment if the ethics
148148 or medical committee determines during the review described by
149149 Subsection (a) that the physician refused to honor a patient's
150150 advance directive or a health care or treatment decision made by or
151151 on behalf of the patient for a reason prohibited by Section
152152 166.0455.
153153 (d) If the attending physician, the patient, or the person
154154 responsible for the health care decisions of the individual does
155155 not agree with the decision reached during the review process under
156156 Subsection (b), the physician shall make a reasonable effort, in
157157 accordance with rules adopted by the executive commissioner, to
158158 transfer the patient to a physician who is willing to comply with
159159 the directive. If the patient is a patient in a health care
160160 facility, the facility's personnel shall assist the physician in
161161 arranging the patient's transfer to:
162162 (1) another physician;
163163 (2) an alternative care setting within that facility;
164164 or
165165 (3) another facility.
166166 (e) If the patient or the person responsible for the health
167167 care decisions of the patient is requesting life-sustaining
168168 treatment that the attending physician has decided and the ethics
169169 or medical committee has affirmed is medically inappropriate
170170 treatment, the patient shall be given available life-sustaining
171171 treatment pending transfer under Subsection (d). This subsection
172172 does not authorize withholding or withdrawing pain management
173173 medication, medical procedures necessary to provide comfort, or any
174174 other health care provided to alleviate a patient's pain. The
175175 patient is responsible for any costs incurred in transferring the
176176 patient to another facility. The attending physician, any other
177177 physician responsible for the care of the patient, and the health
178178 care facility are not obligated to provide life-sustaining
179179 treatment after the 45th [10th] day after both the written decision
180180 and the patient's medical record required under Subsection (b) are
181181 provided to the patient or the person responsible for the health
182182 care decisions of the patient unless ordered to do so under
183183 Subsection (g), except that artificially administered nutrition
184184 and hydration must be provided unless, based on reasonable medical
185185 judgment, providing artificially administered nutrition and
186186 hydration would:
187187 (1) hasten the patient's death;
188188 (2) be medically contraindicated such that the
189189 provision of the treatment seriously exacerbates life-threatening
190190 medical problems not outweighed by the benefit of the provision of
191191 the treatment;
192192 (3) result in substantial irremediable physical pain
193193 not outweighed by the benefit of the provision of the treatment;
194194 (4) be medically ineffective in prolonging life; or
195195 (5) be contrary to the patient's or surrogate's
196196 clearly documented desire not to receive artificially administered
197197 nutrition or hydration.
198198 (g) At the request of the patient or the person responsible
199199 for the health care decisions of the patient, the appropriate
200200 [district or county] court shall extend the time period provided
201201 under Subsection (e) [only] if the court finds, by a preponderance
202202 of the evidence, that there is a reasonable expectation that a
203203 physician or health care facility that will honor the patient's
204204 directive will be found if the time extension is granted.
205205 SECTION 5. Subchapter B, Chapter 166, Health and Safety
206206 Code, is amended by adding Sections 166.0463 and 166.0465 to read as
207207 follows:
208208 Sec. 166.0463. ETHICS OR MEDICAL COMMITTEE MEMBERS. (a) An
209209 individual may not be a member of an ethics or medical committee of
210210 a health care facility if the individual or individual's spouse:
211211 (1) is employed by or participates in the management
212212 of the facility or another affiliated facility;
213213 (2) owns or controls, directly or indirectly, an
214214 interest in the facility or another affiliated facility; or
215215 (3) uses or receives a substantial amount of tangible
216216 goods, services, or money from the facility or another affiliated
217217 facility.
218218 (b) An ethics or medical committee must include as members:
219219 (1) if the patient is an adherent or member of a
220220 recognized religious organization, a chaplain, spiritual advisor,
221221 or spiritual care professional of that religious organization;
222222 (2) an individual with experience as an advocate for
223223 patients and patients' family caregivers; and
224224 (3) a representative of an established patient
225225 advocacy organization.
226226 Sec. 166.0465. COURT PROCEEDINGS; APPEAL; FILING FEE AND
227227 COURT COSTS. (a) A patient, the person responsible for the
228228 patient's health care decisions, or the person who has made the
229229 decision regarding the advance directive or treatment decision may
230230 file a motion for injunctive relief in any county court at law,
231231 court having probate jurisdiction, or district court, including a
232232 family district court, based on:
233233 (1) a request for extension of time to effect a patient
234234 transfer for relief under Section 166.046(g); or
235235 (2) an allegation that a physician or other health
236236 care professional, health care facility, or ethics or medical
237237 committee is violating or threatening to violate this chapter.
238238 (b) The person filing a motion under Subsection (a) shall
239239 immediately serve a copy of the motion on the defendant.
240240 (c) The court shall promptly set a time for a hearing on a
241241 motion filed under Subsection (a) and shall keep a record of all
242242 testimony and other oral proceedings in the action. The court shall
243243 rule on the motion and issue written findings of fact and
244244 conclusions of law not later than the fifth business day after the
245245 date the motion is filed with the court.
246246 (d) The time for the hearing and the date by which the court
247247 must rule on the motion under Subsection (c) may be extended, for
248248 good cause shown, by the court.
249249 (e) Any party may appeal the decision of the court under
250250 Subsection (c) to the court of appeals having jurisdiction over
251251 civil matters in the county in which the motion was filed by filing
252252 a notice of appeal with the clerk of the court that ruled on the
253253 motion not later than the first business day after the date the
254254 decision of the court was issued.
255255 (f) On receipt of a notice of appeal under Subsection (e),
256256 the clerk of the court that ruled on the motion shall deliver a copy
257257 of the notice of appeal and record on appeal to the clerk of the
258258 court of appeals. On receipt of the notice and record, the clerk of
259259 the court of appeals shall place the appeal on the docket of the
260260 court, and the court of appeals shall promptly issue an expedited
261261 briefing schedule and set a time for a hearing.
262262 (g) The court of appeals shall rule on an appeal under
263263 Subsection (f) not later than the fifth business day after the date
264264 the notice of appeal is filed with the court that ruled on the
265265 motion.
266266 (h) The times for the filing of briefs, the hearing, and the
267267 date by which the court of appeals must rule on the appeal under
268268 Subsection (g) may be extended, for good cause shown, by the court
269269 of appeals.
270270 (i) Any party may file a petition for review of the decision
271271 of the court of appeals under Subsection (g) with the clerk of the
272272 supreme court not later than the third business day after the date
273273 the decision of the court of appeals was issued. Other parties may
274274 file responses not later than the third business day after the date
275275 the petition for review was filed. The supreme court shall grant,
276276 deny, refuse, or dismiss the petition, without regard to whether a
277277 reply to any response has been filed, not later than the third
278278 business day after the date the response was due. If the supreme
279279 court grants the petition for review, the court shall exercise the
280280 court's sound discretion in determining how expeditiously to hear
281281 and decide the case.
282282 (j) If a motion is filed under Subsection (a) and the
283283 dispute concerns whether life-sustaining treatment should be
284284 provided to the patient, life-sustaining treatment must be provided
285285 through midnight of the day by which a notice of appeal must be
286286 filed unless the court directs that the life-sustaining treatment
287287 be provided for a longer period. If a notice of appeal under
288288 Subsection (e) is filed, life-sustaining treatment must be provided
289289 through midnight of the day by which a petition for review to the
290290 supreme court must be filed, unless the court of appeals directs
291291 that the life-sustaining treatment be provided for a longer period.
292292 If a petition for review to the supreme court is filed under
293293 Subsection (i), life-sustaining treatment must be provided through
294294 midnight of the day on which the supreme court denies, refuses, or
295295 dismisses the petition or issues a ruling on the merits, unless the
296296 supreme court directs that the life-sustaining treatment be
297297 provided for a longer period.
298298 (k) A filing fee or court cost may not be assessed for any
299299 proceeding in a trial or appellate court under this section.
300300 SECTION 6. Section 166.051, Health and Safety Code, is
301301 amended to read as follows:
302302 Sec. 166.051. LEGAL RIGHT OR RESPONSIBILITY NOT AFFECTED.
303303 This subchapter does not impair or supersede any legal right or
304304 responsibility a person may have to effect the withholding or
305305 withdrawal of life-sustaining treatment in a lawful manner,
306306 provided that if an attending physician or health care facility is
307307 unwilling to honor and comply with a patient's advance directive or
308308 a treatment decision to provide life-sustaining treatment for a
309309 reason permitted by Section 166.046(a-1) and not prohibited by
310310 Section 166.0455, life-sustaining treatment is required to be
311311 provided the patient, but only until a reasonable opportunity has
312312 been afforded for transfer of the patient to another physician or
313313 health care facility willing to comply with the advance directive
314314 or treatment decision.
315315 SECTION 7. Sections 166.052(a) and (b), Health and Safety
316316 Code, are amended to read as follows:
317317 (a) In cases in which the attending physician refuses to
318318 honor an advance directive or health care or treatment decision
319319 requesting the provision of life-sustaining treatment, the
320320 statement required by Section 166.046(b)(3)(A) shall be in
321321 substantially the following form:
322322 When There Is A Disagreement About Medical Treatment: The
323323 Physician Recommends Against Certain Life-Sustaining Treatment
324324 That You Wish To Continue
325325 You have been given this information because you have
326326 requested life-sustaining treatment* for yourself as the patient or
327327 on behalf of the patient, as applicable, which the attending
328328 physician believes is not medically appropriate. This information
329329 is being provided to help you understand state law, your rights, and
330330 the resources available to you in such circumstances. It outlines
331331 the process for resolving disagreements about treatment among
332332 patients, families, and physicians. It is based upon Section
333333 166.046 of the Texas Advance Directives Act, codified in Chapter
334334 166, Texas Health and Safety Code.
335335 When an attending physician refuses to comply with an advance
336336 directive or other request for life-sustaining treatment because of
337337 the physician's judgment that the treatment would be medically
338338 inappropriate, the case will be reviewed by an ethics or medical
339339 committee. Life-sustaining treatment will be provided through the
340340 review.
341341 You will receive notification of this review at least seven
342342 days [48 hours] before a meeting of the committee related to your
343343 case. You are entitled to attend and participate in the entire
344344 meeting with an attorney and patient advocate. With your
345345 agreement, the meeting may be held sooner than 48 hours, if
346346 possible.
347347 A physician or other health care professional, a health care
348348 facility, or an ethics or medical committee may not deny a patient
349349 life-sustaining treatment based on:
350350 1. the lesser value the physician or professional,
351351 facility, or committee places on sustaining the life of an elderly,
352352 disabled, or terminally ill patient compared to the value of
353353 sustaining the life of a patient who is younger, not disabled, or
354354 not terminally ill;
355355 2. a disagreement between the physician or professional,
356356 facility, or committee and the patient, or the person authorized to
357357 make a treatment decision for the patient under Section 166.039,
358358 over the greater weight the patient or person places on sustaining
359359 the patient's life than the risk of disability; or
360360 3. the patient's financial condition.
361361 Life-sustaining treatment may be denied if the treatment is:
362362 1. futile because the treatment is physiologically
363363 ineffective in achieving the specific intended benefit to the
364364 patient as intended by or on behalf of the patient; or
365365 2. medically inappropriate because providing the treatment
366366 to the patient would clearly create a substantially greater risk of
367367 causing or hastening the death of the patient than would
368368 withholding or withdrawing it.
369369 You are entitled to receive a written explanation of the
370370 decision reached during the review process and the medical judgment
371371 and reason leading to the decision.
372372 If after this review process both the attending physician and
373373 the ethics or medical committee conclude that life-sustaining
374374 treatment is medically inappropriate and yet you continue to
375375 request such treatment, then the following procedure will occur:
376376 1. The physician, with the help of the health care facility,
377377 will assist you in trying to find a physician and facility willing
378378 to provide the requested treatment.
379379 2. You are being given a list of health care providers,
380380 licensed physicians, health care facilities, and referral groups
381381 that have volunteered their readiness to consider accepting
382382 transfer, or to assist in locating a provider willing to accept
383383 transfer, maintained by the Department of State Health Services.
384384 You may wish to contact providers, facilities, or referral groups
385385 on the list or others of your choice to get help in arranging a
386386 transfer.
387387 3. The patient will continue to be given life-sustaining
388388 treatment until the patient can be transferred to a willing
389389 provider for up to 45 [10] days from the time you were given both the
390390 committee's written decision and explanation that life-sustaining
391391 treatment is not appropriate and the patient's medical record. The
392392 patient will continue to be given after the 45-day [10-day] period
393393 treatment to enhance pain management and reduce suffering,
394394 including artificially administered nutrition and hydration,
395395 unless, based on reasonable medical judgment, providing
396396 artificially administered nutrition and hydration would hasten the
397397 patient's death, be medically contraindicated such that the
398398 provision of the treatment seriously exacerbates life-threatening
399399 medical problems not outweighed by the benefit of the provision of
400400 the treatment, result in substantial irremediable physical pain not
401401 outweighed by the benefit of the provision of the treatment, be
402402 medically ineffective in prolonging life, or be contrary to the
403403 patient's or surrogate's clearly documented desires.
404404 4. If a transfer can be arranged, the patient will be
405405 responsible for the costs of the transfer.
406406 5. If a provider cannot be found willing to give the
407407 requested treatment within 45 [10] days, life-sustaining treatment
408408 may be withdrawn unless a court of law has ruled otherwise [granted
409409 an extension].
410410 6. You may ask the [appropriate district or county] court to
411411 extend the 45-day [10-day] period if the court finds that there is a
412412 reasonable expectation that you may find a physician or health care
413413 facility willing to provide life-sustaining treatment if the
414414 extension is granted. Patient medical records will be provided to
415415 the patient or surrogate in accordance with Section 241.154, Texas
416416 Health and Safety Code.
417417 7. The law gives you the right to seek a court order to
418418 require a physician or other health care professional, health care
419419 facility, or ethics or medical committee to comply with your rights
420420 under the Texas Advance Directives Act if the physician or
421421 professional, facility, or committee is violating or threatening to
422422 violate a provision of that Act. You may wish to talk to legal
423423 counsel for further information about your right to seek a court
424424 order.
425425 *"Life-sustaining treatment" means treatment that, based on
426426 reasonable medical judgment, sustains the life of a patient and
427427 without which the patient will die. The term includes both
428428 life-sustaining medications and artificial life support, such as
429429 mechanical breathing machines, kidney dialysis treatment, and
430430 artificially administered nutrition and hydration. The term does
431431 not include the administration of pain management medication or the
432432 performance of a medical procedure considered to be necessary to
433433 provide comfort care, or any other medical care provided to
434434 alleviate a patient's pain.
435435 (b) In cases in which the attending physician refuses to
436436 comply with an advance directive or treatment decision requesting
437437 the withholding or withdrawal of life-sustaining treatment, the
438438 statement required by Section 166.046(b)(3)(A) shall be in
439439 substantially the following form:
440440 When There Is A Disagreement About Medical Treatment: The
441441 Physician Recommends Life-Sustaining Treatment That You Wish To
442442 Stop
443443 You have been given this information because you have
444444 requested the withdrawal or withholding of life-sustaining
445445 treatment* for yourself as the patient or on behalf of the patient,
446446 as applicable, and the attending physician disagrees with and
447447 refuses to comply with that request. The information is being
448448 provided to help you understand state law, your rights, and the
449449 resources available to you in such circumstances. It outlines the
450450 process for resolving disagreements about treatment among
451451 patients, families, and physicians. It is based upon Section
452452 166.046 of the Texas Advance Directives Act, codified in Chapter
453453 166, Texas Health and Safety Code.
454454 When an attending physician refuses to comply with an advance
455455 directive or other request for withdrawal or withholding of
456456 life-sustaining treatment for any reason, the case will be reviewed
457457 by an ethics or medical committee. Life-sustaining treatment will
458458 be provided through the review.
459459 You will receive notification of this review at least seven
460460 days [48 hours] before a meeting of the committee related to your
461461 case. You are entitled to attend and participate in the entire
462462 meeting with an attorney and patient advocate. With your
463463 agreement, the meeting may be held sooner than 48 hours, if
464464 possible.
465465 You are entitled to receive a written explanation of the
466466 decision reached during the review process and the medical judgment
467467 and reason leading to the decision.
468468 If you or the attending physician do not agree with the
469469 decision reached during the review process, and the attending
470470 physician still refuses to comply with your request to withhold or
471471 withdraw life-sustaining treatment, then the following procedure
472472 will occur:
473473 1. The physician, with the help of the health care facility,
474474 will assist you in trying to find a physician and facility willing
475475 to withdraw or withhold the life-sustaining treatment.
476476 2. You are being given a list of health care providers,
477477 licensed physicians, health care facilities, and referral groups
478478 that have volunteered their readiness to consider accepting
479479 transfer, or to assist in locating a provider willing to accept
480480 transfer, maintained by the Department of State Health
481481 Services. You may wish to contact providers, facilities, or
482482 referral groups on the list or others of your choice to get help in
483483 arranging a transfer.
484484 3. The law gives you a right to seek a court order to require
485485 a physician or other health care professional, health care
486486 facility, or ethics or medical committee to comply with your rights
487487 under the Texas Advance Directives Act if the physician, facility,
488488 or committee is violating or threatening to violate a provision of
489489 that Act. You may wish to talk to legal counsel for further
490490 information about your right to seek a court order.
491491 *"Life-sustaining treatment" means treatment that, based on
492492 reasonable medical judgment, sustains the life of a patient and
493493 without which the patient will die. The term includes both
494494 life-sustaining medications and artificial life support, such as
495495 mechanical breathing machines, kidney dialysis treatment, and
496496 artificially administered nutrition and hydration. The term does
497497 not include the administration of pain management medication or the
498498 performance of a medical procedure considered to be necessary to
499499 provide comfort care, or any other medical care provided to
500500 alleviate a patient's pain.
501501 SECTION 8. Subchapter B, Chapter 166, Health and Safety
502502 Code, is amended by adding Section 166.054 to read as follows:
503503 Sec. 166.054. REPORTING REQUIREMENTS REGARDING ETHICS OR
504504 MEDICAL COMMITTEE. (a) A health care facility shall submit an
505505 annual report to the commission, in the form and manner prescribed
506506 by commission rule, of all meetings of an ethics or medical
507507 committee held under Section 166.046 during the preceding year.
508508 (b) The report required by Subsection (a) must include:
509509 (1) whether the health care facility held any ethics
510510 or medical committee meetings during the preceding year; and
511511 (2) for each meeting held during the preceding year:
512512 (A) whether treatment was withheld or withdrawn
513513 without the consent of the patient or person authorized to make
514514 treatment decisions on behalf of the patient after the meeting; and
515515 (B) whether the patient died while receiving
516516 life-sustaining treatment at the facility.
517517 SECTION 9. Section 166.158(c), Health and Safety Code, is
518518 amended to read as follows:
519519 (c) A principal's health or residential care provider who
520520 finds it impossible to follow a directive by the agent because of a
521521 conflict with this subchapter or the medical power of attorney
522522 shall inform the agent as soon as is reasonably possible. The agent
523523 may select another attending physician. The procedures and
524524 limitations established under Sections 166.045, 166.0455, and
525525 166.046 apply if the agent's directive concerns providing,
526526 withholding, or withdrawing life-sustaining treatment.
527527 SECTION 10. Section 166.166, Health and Safety Code, is
528528 amended to read as follows:
529529 Sec. 166.166. OTHER RIGHTS OR RESPONSIBILITIES NOT
530530 AFFECTED. This subchapter does not limit or impair any legal right
531531 or responsibility that any person, including a physician or health
532532 or residential care provider, may have to make or implement health
533533 care decisions on behalf of a person, provided that if an attending
534534 physician or health care facility is unwilling to honor and comply
535535 with a patient's advance directive or a treatment decision to
536536 provide life-sustaining treatment for a reason permitted by Section
537537 166.046(a-1) and not prohibited by Section 166.0455,
538538 life-sustaining treatment is required to be provided the patient,
539539 but only until a reasonable opportunity has been afforded for
540540 transfer of the patient to another physician or health care
541541 facility willing to comply with the advance directive or treatment
542542 decision.
543543 SECTION 11. Not later than December 1, 2019, the executive
544544 commissioner of the Health and Human Services Commission shall
545545 adopt rules for the transfer of a patient as provided by Section
546546 166.046(d), Health and Safety Code, as amended by this Act.
547547 SECTION 12. Not later than December 1, 2019, the Supreme
548548 Court of Texas shall issue the rules and prescribe the forms
549549 necessary for the process established by Section 166.0465, Health
550550 and Safety Code, as added by this Act. The rules shall prescribe
551551 the method of service of the application under Section 166.0465,
552552 Health and Safety Code, and may require filing and service of
553553 notices, petitions, and briefs electronically to the extent the
554554 Supreme Court of Texas considers appropriate.
555555 SECTION 13. The changes in law made by this Act apply only
556556 to a health care or treatment decision made on or after the
557557 effective date of this Act.
558558 SECTION 14. This Act takes effect immediately if it
559559 receives a vote of two-thirds of all the members elected to each
560560 house, as provided by Section 39, Article III, Texas Constitution.
561561 If this Act does not receive the vote necessary for immediate
562562 effect, this Act takes effect September 1, 2019.